Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 2Lymphoid 2Genitourinary 2Tumor-Agnostic 1NET 1Endocrine 1

Conditions

Neoplastic Cells, Circulating 1Neoplasms 1Lung Neoplasms 1Lung Cancer Metastatic 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Needles × Thoracic × Clear all
NCT05706883 2024-04-05

ProphetaPro

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Completed
348 enrolled
Thoracic

Lung Cancer Metastatic

NCT02507778 2016-09-23

Circulating Tumor Cells Spillage After Pulmonary Biopsy

Rabin Medical Center

Phase NA Unknown
40 enrolled
Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡